Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy: A Subgroup Analysis of Patients ≥ 65 Years of Age

BACKGROUND: Opioid-induced constipation (OIC), the most common side effect of opioid treatment, is under-recognized and undertreated in older patients. Naldemedine, an oral, peripherally acting μ-opioid receptor antagonist (PAMORA), is approved in Japan, the United States, and the European Union for...

Descripción completa

Detalles Bibliográficos
Autores principales: Wild, James, Webster, Lynn, Yamada, Tadaaki, Hale, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096364/
https://www.ncbi.nlm.nih.gov/pubmed/32086791
http://dx.doi.org/10.1007/s40266-020-00753-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096364/
https://www.ncbi.nlm.nih.gov/pubmed/32086791
http://dx.doi.org/10.1007/s40266-020-00753-2

Ejemplares similares